Cargando…

Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease

BACKGROUND: Associations between blood pressure (BP) with age at onset of Huntington’s disease (HD) have reported inconsistent findings. We used Mendelian randomization (MR) to assess effects of BP and lowering systolic BP (SBP) via the genes encoding targets of antihypertensive drugs on age at onse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yahui, Li, Mao, Bai, Jiongming, Wang, Haoran, Huang, Xusheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207760/ https://www.ncbi.nlm.nih.gov/pubmed/37226269 http://dx.doi.org/10.1186/s13023-023-02734-1

Ejemplares similares

Hypertension, Antihypertensive Use and the Delayed‐Onset of Huntington's Disease
por: Steventon, Jessica J., et al.
Publicado: (2020)

Association between Genetically Proxied Inhibition of HMG-CoA Reductase and Age at Onset of Huntington’s Disease
por: Zhu, Yahui, et al.
Publicado: (2022)

Repetitive nerve stimulation on survival in amyotrophic lateral sclerosis
por: Zhu, Yahui, et al.
Publicado: (2023)

Age-at-onset in Huntington disease
por: Orth, Michael, et al.
Publicado: (2011)

Does arterial hypertension influence the onset of Huntington's disease?
por: Valcárcel-Ocete, Leire, et al.
Publicado: (2018)

Influence of Age of Onset on Huntington’s Disease Phenotype
por: Kwa, Lauren, et al.
Publicado: (2020)

Sporadic adult-onset neuronal intranuclear inclusion disease without high-intensity signal on DWI and T2WI: a case report
por: Wang, Hongfen, et al.
Publicado: (2022)

PGC-1alpha as modifier of onset age in Huntington disease
por: Taherzadeh-Fard, Elahe, et al.
Publicado: (2009)

Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset
por: Gardiner, Sarah L., et al.
Publicado: (2018)

Overlap between age-at-onset and disease-progression determinants in Huntington disease
por: Aziz, N. Ahmad, et al.
Publicado: (2018)

The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington’s Disease
por: Schultz, Jordan L., et al.
Publicado: (2020)

No association between polymorphisms in the BDNF gene and age at onset in Huntington disease
por: Mai, Maren, et al.
Publicado: (2006)

Disease Onset in Huntington's Disease: When Is the Conversion?
por: Oosterloo, Mayke, et al.
Publicado: (2021)

Antihypertensive therapy, new-onset diabetes, and cardiovascular disease
por: Basile, J N
Publicado: (2009)

The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension
por: Pawlak-Chomicka, Regina, et al.
Publicado: (2022)

The gene coding for PGC-1α modifies age at onset in Huntington's Disease
por: Weydt, Patrick, et al.
Publicado: (2009)

Brain structure in juvenile-onset Huntington disease
por: Tereshchenko, Alexander, et al.
Publicado: (2019)

Special Issue: Juvenile Onset Huntington’s Disease
por: Nopoulos, Peg C.
Publicado: (2020)

Autonomic Changes in Juvenile-Onset Huntington’s Disease
por: Schultz, Jordan L., et al.
Publicado: (2020)

Behavioral Deficits in Juvenile Onset Huntington’s Disease
por: Langbehn, Kathleen E., et al.
Publicado: (2020)

Huntington’s Disease Presenting as Adult-Onset Parkinsonism
por: Kwak, In Hee, et al.
Publicado: (2022)

Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial
por: Serrano, José C. E., et al.
Publicado: (2023)

New-onset diabetes and antihypertensive treatment
por: Grimm, Christine, et al.
Publicado: (2010)

Failure to confirm influence of Methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease
por: Hansen, Wiebke, et al.
Publicado: (2005)

Glutathione S-Transferase Ω 1 variation does not influence age at onset of Huntington's disease
por: Arning, Larissa, et al.
Publicado: (2004)

Modulation at Age of Onset in Tunisian Huntington Disease Patients: Implication of New Modifier Genes
por: Hmida-Ben Brahim, Dorra, et al.
Publicado: (2014)

Effect of Body Weight on Age at Onset in Huntington Disease: A Mendelian Randomization Study
por: van der Burg, Jorien M.M., et al.
Publicado: (2021)

Presynaptic Dopaminergic Dysfunction Was Overestimated in Huntington’s Disease Presenting as Young Age-Onset Parkinsonism
por: Kim, Taewon, et al.
Publicado: (2022)

Huntington’s disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
por: Lobanov, Sergey V., et al.
Publicado: (2022)

Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension
por: Li, Bingwei, et al.
Publicado: (2020)

Genetically proxied antidiabetic drugs targets and stroke risk
por: Zhu, Yahui, et al.
Publicado: (2023)

The Impact of Different Antihypertensive Drugs on Cardiovascular Risk in Isolated Systolic Hypertension with Type 2 Diabetes Patients
por: Gao, Ming, et al.
Publicado: (2022)

Pharmacometabolomic study of drug response to antihypertensive medications for hypertension marker identification in Han Chinese individuals in Taiwan
por: Liang, Yu-Jen, et al.
Publicado: (2022)

Genetic analysis of polymorphisms in the kalirin gene for association with age-at-onset in European Huntington disease patients
por: Tsai, Yu-Chun, et al.
Publicado: (2012)

Factors associated with intensification of antihypertensive drug therapy in patients with poorly controlled hypertension
por: Siga, Olga, et al.
Publicado: (2019)

Effects of Antihypertensive Drugs on Cognitive Function in Elderly Patients with Hypertension: A Review
por: Yang, Wei, et al.
Publicado: (2021)

Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study
por: Zhao, Cong, et al.
Publicado: (2023)

Is Yangxue Qingnao Granule Combined with Antihypertensive Drugs, a New Integrative Medicine Therapy, More Effective Than Antihypertensive Therapy Alone in Treating Essential Hypertension?
por: Wang, Jie, et al.
Publicado: (2013)

Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease
por: Aziz, N. Ahmad, et al.
Publicado: (2009)

Oromandibular Dyskinesia as the Initial Manifestation of Late-Onset Huntington Disease
por: Oh, Dong-Seok, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8ip18793p3878l0lnha2ls5gh4